Human Genome Sciences, Inc. (HGSI) Balance Sheet

Click line-items for a historical chart and %

Cash and cash equivalents	349.96M
Short-term investments	120.21M
Accounts receivable	58.33M
Collaboration receivables
Inventory	22.76M
Prepaid expenses and other current assets	10.5M
Total current assets	594.16M
Marketable securities	204.19M
Property, plant and equipment (net of accumulated depreciation)	245.07M
Restricted investments	79.66M
Collaboration receivables, non-current
Inventory, non-current	135.83M
Other assets	11.04M
TOTAL ASSETS	1.28B
Accounts payable and accrued expenses	49.5M
Accrued payroll and related taxes	29.21M
Convertible subordinated debt
Collaboration payable	36.91M
Deferred revenues	9.61M
Accrued exit expenses
Other current liabilities	1.05M
Total current liabilities	331.73M
Convertible subordinated debt, non-current
Lease financing	252.82M
Other liabilities	19.44M
Total liabilities	975M
Preferred stock	0
Common stock	2M
Additional paid-in capital	3.28B
Accumulated other comprehensive income	5.64M
Accumulated deficit	-2.99B
Total stockholders' equity	300.65M
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	1.28B

Entities mentioned with HGSI

View All Entities